CLIMB BIO, INC. Payments for Restructuring
CLIMB BIO, INC. (CLYM) reported Payments for Restructuring of $3.33 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2025-03-25
- CLIMB BIO, INC. payments for restructuring for the quarter ending 2024-12-31 was $722.00K.
- CLIMB BIO, INC. payments for restructuring for the quarter ending 2024-09-30 was $1.54M, a 202.35% increase year-over-year.
- CLIMB BIO, INC. payments for restructuring for the quarter ending 2024-06-30 was $281.00K, a 69.42% decline year-over-year.
- CLIMB BIO, INC. payments for restructuring for the quarter ending 2024-03-31 was $782.00K, a 85.76% decline year-over-year.
- CLIMB BIO, INC. payments for restructuring for fiscal 2024 was $3.33M, a 57.88% decline from fiscal 2023.
- CLIMB BIO, INC. payments for restructuring for fiscal 2023 was $7.91M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2024-12-31 | $722.00K derived: 10-K 12 month − 3 quarters · filed 2025-03-25 | $2.27M derived: sum of 2 quarters · filed 2025-03-25 | $2.55M derived: sum of 3 quarters · filed 2025-03-25 | $3.33M 10-K · filed 2025-03-25 |
| 2024-09-30 | $1.54M 10-Q · filed 2024-11-12 | $1.83M derived: sum of 2 quarters · filed 2024-11-12 | $2.61M derived: sum of 3 quarters · filed 2024-11-12 | |
| 2024-06-30 | $281.00K 10-Q · filed 2024-11-12 | $1.06M derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2024-03-31 | $782.00K 10-Q · filed 2024-11-12 | |||
| 2023-12-31 | $7.91M 10-K · filed 2025-03-25 | |||
| 2023-09-30 | $511.00K 10-Q · filed 2023-11-14 | $1.43M derived: sum of 2 quarters · filed 2023-11-14 | $6.92M derived: sum of 3 quarters · filed 2023-11-14 | |
| 2023-06-30 | $919.00K 10-Q · filed 2023-11-14 | $6.41M derived: sum of 2 quarters · filed 2023-11-14 | ||
| 2023-03-31 | $5.49M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |